Home Conference Coverage

Conference Coverage

Chest 2019

ASCO 2018

research

Whole-Genome Sequencing as an Alternative to Analyze Copy Number Abnormalities in AML, MDS and...

Study: VTE Rates May Not Be Higher Than Expected in COVID-19

Identifying Clinical Predictors of VTE in AML and MDS

Assessing Hyperferritinemia as Predictive Biomarker in CMML

Machine Learning to Identify Patients with Lower-Risk MDS

Addition of Ribociclib to Endocrine Therapy Improves Survival in Metastatic Breast Cancer

“Practice-Changing” Results Seen With Targeted Therapy in HER2-Low Metastatic Breast Cancer

These Factors Predict Survival in Patients With HER2-Positive Breast Cancer and Brain Metastases

Investigational Treatment Combo Produces Responses in HER2-Positive Metastatic Breast Cancer

Load more
Subscribe to RSS